Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morgane Lacour

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Genome Medicine|June 27, 2022
Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypesCatherine Schramm, Camille Charbonnier, Aline Zaréa, et al.
Plos Medicine|March 29, 2017
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic casesHélène-Marie Lanoiselée, Gaël Nicolas, David Wallon, et al.
Journal of Alzheimer'S Disease : JAD|August 6, 2019
Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 YearsMorgane Lacour, Olivier Quenez, Anne Rovelet-Lecrux, et al.
Molecular Psychiatry|May 29, 2026
Assessing the de novo paradigm in sporadic early-onset Alzheimer disease triosAline Zarea, Kevin Cassinari, François Lecoquierre, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 28, 2024
Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screeningGaël Nicolas, Aline Zaréa, Morgane Lacour, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Genome Medicine|June 27, 2022
Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypesCatherine Schramm, Camille Charbonnier, Aline Zaréa, et al.
Plos Medicine|March 29, 2017
APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic casesHélène-Marie Lanoiselée, Gaël Nicolas, David Wallon, et al.
Journal of Alzheimer'S Disease : JAD|August 6, 2019
Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 YearsMorgane Lacour, Olivier Quenez, Anne Rovelet-Lecrux, et al.
Molecular Psychiatry|May 29, 2026
Assessing the de novo paradigm in sporadic early-onset Alzheimer disease triosAline Zarea, Kevin Cassinari, François Lecoquierre, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 28, 2024
Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screeningGaël Nicolas, Aline Zaréa, Morgane Lacour, et al.
Pageof 1